•  
• Tweet
•  
•        Print
•  
•         Track Keywords
•  
• 

B. G., Opalesque Geneva for New Managers:

Catalio Capital Management, LP, a multi-strategy life sciences investment firm with more than $1bn in AuM, has launched a dedicated public equities hedge fund investment strategy focused on identifying compelling life science investment opportunities globally.

Life science is the study of living organisms and life processes. Biology, medicine, agriculture and biotechnology are the most obvious examples of the discipline.

In connection with the launch of the vehicle, the investment team from HealthCor Management, a healthcare hedge fund, along with key members of its operations, financial, administrative and marketing divisions, have agreed to join Catalio to help build out the strategy.

Catalio recently acquired HealthCor. The latter was launched in 2005 as a long/short equity/value fund focused on healthcare and life sciences. HealthCor's founders Art Cohen and Joe Healey join the firm as senior advisors.

Catalio was founded in 2020 by Messrs. Petrocheilos and ......................

To view our full article Click here